Therini Bio, Inc. develops fibrin-targeting immunotherapies to treat neurodegenerative diseases such as Alzheimer's Disease and Diabetic Macular Edema.

AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.